Expeditionary and Special Programs Division (X-Labs)
Liberty's Expeditionary and Special Programs Division leverages the combined power of precision medicine, novel biology, and bioinformatics to develop breakthroughs that result in new medicines and biological capabilities for healthcare, industry, space exploration agencies, and governments across the globe.
The Exploratory Group is the pure research and development arm of Liberty BioSecurity. The group is charged with pushing the boundaries of science and engineering to develop next generation biological products for Liberty. With exclusive access to novel biology collections obtained by governments and academic communities across the globe, the exploratory group employs rapid proprietary screening methodologies to assess the commercial viability and product potential of novel chemical and biological compounds. This interdisciplinary team of scientists and bioinformaticians work together to demonstrate preliminary efficacy of new products derived from novel biological species.
Applied Research Group The Applied Research Group at Liberty BioSecurity develops engineering solutions that ensure the stability and efficacy of innovative biological products developed within Liberty BioSecurity. Drawing upon a multidisciplinary team of scientists with decades of industry expertise, the applied research group designs the tools required to stress Liberty’s products under 'real world' application scenarios in the clinic, in support of space missions, and for governments seeking to mitigate the threats posed by naturally occurring and man-made biological threats. The solutions developed by this team allow Liberty's customers to deploy these new biological products in the most challenging of conditions or tailor them to the individual needs of patients, physicians, engineers or national security practitioners.
Biochemistry and Molecular Biology Group
The Biochemistry and Molecular Biology Group is responsible for the identification, development and characterization of biological therapeutics and innovative technologies within the company’s extensive portfolio of owned and exclusively licensed biology. The team uses a broad range of unique biochemistry capabilities, in conjunction with recombinant gene expression, to refine, isolate and purify biomolecules of interest from complex and in many cases, novel biological mixtures. and is constantly assessing the overall quality of the products using standardized enzyme activity assays and spectroscopic analysis. The Lab works closely with clients to build custom-tailored technologies that outperform products available through competitors, or to create entirely new product lines. The Biochemistry and Molecular Biology group provides expertise in proteomics experimental design and analysis as part of an integrated systems of biology pipeline to derive new products from novel biological and biochemical processes.
Bioinformatics Group The bioinformatics group utilizes the latest advances in sequencing technology, coupled with capabilities derived from Liberty’s own Bioinformatics Department, to support Liberty's bioengineering and medical activities. With extensive expertise in big data, the bioinformatics group can process, curate and optimize large data sets for use with proprietary algorithms and artificial intelligence pipelines. Through the use of their unique in silico bioinformatic pipelines, the team extracts unique forms of metadata that in turn result in discoveries as varied as the identification of new organisms, to screening for new mutations within the human genome, to finding entirely new genes that will be the foundation of next-generation classes of drugs and bioengineering solutions.